Arthur D Little
We’ve been linking people, technology and strategy to make a powerful difference for our clients
Eureka! on Steroids AI-driven research, development & innovation
https://www.adlittle.com/en/eureka-steroids
Artificial intelligence is driving a new era of breakthroughs in research, development, and innovation (R&D&I). From auctioning AI-generated art to solving complex mathematics and unlocking medical discoveries, AI's rapid advancements provide a compelling backdrop for understanding the technology's transformative potential. Arthur D. Little’s Blue Shift Report looks at how AI is reshaping innovation and what lies ahead in this evolving landscape.
October 2018: Christie’s auction house sells a work created by the French artist collective Obvious in collaboration with AI for nearly half a million dollars.
December 2023: A group of researchers reports in Nature that they have solved a previously unsolved mathematics problem by collaborating with generative AI (GenAI).
June 2024: Researchers at the University of Pennsylvania leveraged machine learning (ML) to discover nearly 1 million potential antibiotic compounds, with dozens showing activity against antibiotic-resistant bacteria.
October 2024: two Nobel Prizes were awarded for discoveries related to ML, both in physics and chemistry.
October 2024: Joëlle Barral, head of AI research at Google DeepMind, recently noted, “AI will accelerate research far beyond what we currently imagine.”
A series of AI ripples in the pond of creativity.
Will AI, indeed, augment R&D&I? Will the pace of scientific discoveries significantly increase thanks to AI? What role does AI play in the “Eureka!” moment? What role does AI play in the countless tasks that define R&D&I? These are some of the questions that Arthur D. Little’s (ADL’s) Blue Shift wanted to investigate.